Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02760797 |
Title | A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | FRA | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Memorial Sloan-Kettering Cancer Center | New York | New York | United States | Details | ||
University Pennsylvania Hospital | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Cliniques Universitaires St-Luc | Bruxelles | 1200 | Belgium | Details | ||
Centre Leon Berard; Departement Oncologie Medicale | Lyon | 69373 | France | Details | ||
Institut Claudius Regaud; Departement Oncologie Medicale | Toulouse | 31059 | France | Details | ||
Institut Gustave Roussy; Sitep | VILLEJUIF Cedex | 94805 | France | Details |